Logo image of CRESY

CRESUD S.A.-SPONS ADR (CRESY) Stock Fundamental Analysis

NASDAQ:CRESY - Nasdaq - US2264061068 - ADR - Currency: USD

10.85  -0.29 (-2.6%)

After market: 10.85 0 (0%)

Fundamental Rating

3

CRESY gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Food Products industry. CRESY has a medium profitability rating, but doesn't score so well on its financial health evaluation. CRESY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CRESY had positive earnings in 4 of the past 5 years.
Of the past 5 years CRESY 4 years had a positive operating cash flow.
CRESY Yearly Net Income VS EBIT VS OCF VS FCFCRESY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200B -400B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.01%, CRESY is in line with its industry, outperforming 46.15% of the companies in the same industry.
CRESY has a Return On Equity of 10.99%. This is in the better half of the industry: CRESY outperforms 70.33% of its industry peers.
CRESY has a Return On Invested Capital (2.85%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRESY is significantly below the industry average of 28.20%.
The last Return On Invested Capital (2.85%) for CRESY is above the 3 year average (2.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.01%
ROE 10.99%
ROIC 2.85%
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
CRESY Yearly ROA, ROE, ROICCRESY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

With an excellent Profit Margin value of 10.43%, CRESY belongs to the best of the industry, outperforming 87.91% of the companies in the same industry.
With an excellent Operating Margin value of 14.92%, CRESY belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
CRESY's Operating Margin has been stable in the last couple of years.
CRESY has a Gross Margin of 34.69%. This is in the better half of the industry: CRESY outperforms 78.02% of its industry peers.
In the last couple of years the Gross Margin of CRESY has declined.
Industry RankSector Rank
OM 14.92%
PM (TTM) 10.43%
GM 34.69%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
CRESY Yearly Profit, Operating, Gross MarginsCRESY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CRESY has been reduced compared to 1 year ago.
Compared to 5 years ago, CRESY has less shares outstanding
CRESY has a better debt/assets ratio than last year.
CRESY Yearly Shares OutstandingCRESY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRESY Yearly Total Debt VS Total AssetsCRESY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

CRESY has a Debt/Equity ratio of 1.06. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CRESY (1.06) is worse than 72.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CRESY Yearly LT Debt VS Equity VS FCFCRESY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200B -200B 400B -400B 600B

2.3 Liquidity

A Current Ratio of 1.25 indicates that CRESY should not have too much problems paying its short term obligations.
CRESY has a Current ratio of 1.25. This is in the lower half of the industry: CRESY underperforms 67.03% of its industry peers.
A Quick Ratio of 0.95 indicates that CRESY may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.95, CRESY is in line with its industry, outperforming 53.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.95
CRESY Yearly Current Assets VS Current LiabilitesCRESY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

3

3. Growth

3.1 Past

The earnings per share for CRESY have decreased strongly by -28.19% in the last year.
Looking at the last year, CRESY shows a very strong growth in Revenue. The Revenue has grown by 40.49%.
Measured over the past years, CRESY shows a very strong growth in Revenue. The Revenue has been growing by 71.80% on average per year.
EPS 1Y (TTM)-28.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243%
Revenue 1Y (TTM)40.49%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%42.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRESY Yearly Revenue VS EstimatesCRESY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CRESY Price Earnings VS Forward Price EarningsCRESY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRESY Per share dataCRESY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CRESY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRESUD S.A.-SPONS ADR

NASDAQ:CRESY (8/1/2025, 8:00:00 PM)

After market: 10.85 0 (0%)

10.85

-0.29 (-2.6%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-09 2025-05-09
Earnings (Next)09-03 2025-09-03
Inst Owners15.26%
Inst Owner Change-0.21%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap659.33M
Analysts86.67
Price TargetN/A
Short Float %2.06%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP66.34%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.01%
ROE 10.99%
ROCE 3.61%
ROIC 2.85%
ROICexc 3.31%
ROICexgc 3.34%
OM 14.92%
PM (TTM) 10.43%
GM 34.69%
FCFM N/A
ROA(3y)4.46%
ROA(5y)1.27%
ROE(3y)25.84%
ROE(5y)3.92%
ROIC(3y)2.55%
ROIC(5y)1.98%
ROICexc(3y)2.84%
ROICexc(5y)2.27%
ROICexgc(3y)2.9%
ROICexgc(5y)2.34%
ROCE(3y)3.23%
ROCE(5y)2.51%
ROICexcg growth 3Y84.33%
ROICexcg growth 5Y19.28%
ROICexc growth 3Y83.34%
ROICexc growth 5Y20.03%
OM growth 3Y103.59%
OM growth 5Y-0.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.68%
GM growth 5Y-1.65%
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA 6.08
Cap/Depr 382.52%
Cap/Sales 6.51%
Interest Coverage 1.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.95
Altman-Z N/A
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)595.85%
Cap/Depr(5y)423.1%
Cap/Sales(3y)8.46%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%243%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.49%
Revenue growth 3Y68.04%
Revenue growth 5Y71.8%
Sales Q2Q%42.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.75%
EBIT growth 3Y242.1%
EBIT growth 5Y70.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1613.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-133.39%
OCF growth 3YN/A
OCF growth 5Y5.31%